Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126014262 | 12601426 | 2 | F | 20160804 | 20160728 | 20160812 | EXP | IT-ACCORD-042689 | ACCORD | MARCHEI E, PALMI I, PICHINI S, PACIFICI R, ANTON AIRALDI IR, COSTA ORVAY JA, ET AL. SEGMENTAL HAIR TESTING TO DISCLOSE CHRONIC EXPOSURE TO PSYCHOACTIVE DRUGS. ADICCIONES. 2016 JUN 15;28(3):158-162. | 4.00 | YR | C | M | Y | 0.00000 | 20160812 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126014262 | 12601426 | 1 | PS | QUETIAPINE. | QUETIAPINE | 1 | Oral | 202152 | |||||||||||
126014262 | 12601426 | 2 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 202825 | |||||||||||
126014262 | 12601426 | 3 | SS | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126014262 | 12601426 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126014262 | 12601426 | Drug administration error | |
126014262 | 12601426 | Encephalitis | |
126014262 | 12601426 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |